How imaging techniques used to assess response in skin cancer are changing
Marius Erik Mayerhöfer
What support can doctors provide patients in terms of pyschological well-being?
Melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better PFS
The use of mouse models in melanoma with brain metastases to test new therapies
BRIM-3 trial in melanoma: prognostic factors of overall survival and the issue of salvage therapies
Why uveal melanoma is a good candidate for vaccination and the importance of the abnormal ligandome
The developments of genetic testing and personalized cancer vaccines for patients with skin cancer